About SpectraWAVE
SpectraWAVE is a company based in Waltham (United States) founded in 2012 by Gregg Stone, Guillermo Tearney, and James Muller was acquired by Philips in December 2025. SpectraWAVE has raised $79.88 million across 3 funding rounds from investors including Nova Ventures Group, Philips and Johnson & Johnson Innovation – JJDC. The company has 36 employees as of December 31, 2021. SpectraWAVE offers products and services including HyperVue Imaging System and Starlight Imaging Catheter. SpectraWAVE operates in a competitive market with competitors including Oxford Instruments, Leica Microsystems, IBA, GEN inCode and SD Biosensor, among others.
- Headquarter Waltham, United States
- Employees 36 as on 31 Dec, 2021
- Founders Gregg Stone, Guillermo Tearney, James Muller
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Spectrawave, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$79.88 M (USD)
in 3 rounds
-
Latest Funding Round
$50.29 M (USD), Series B
Sep 04, 2024
-
Investors
Nova Ventures Group
& 8 more
-
Employee Count
36
as on Dec 31, 2021
-
Acquired by
Philips
(Dec 05, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SpectraWAVE
SpectraWAVE offers a comprehensive portfolio of products and services, including HyperVue Imaging System and Starlight Imaging Catheter.
Offers high-resolution intravascular imaging for coronary artery analysis.
Enables imaging in vessels for interventional procedures and plaque assessment.
People of SpectraWAVE
Unlock access to complete
Funding Insights of SpectraWAVE
SpectraWAVE has successfully raised a total of $79.88M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $50.29 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in SpectraWAVE
SpectraWAVE has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Nova Ventures Group, Philips and Johnson & Johnson Innovation – JJDC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm backed by Johnson & Johnson
|
Locked | Locked | Locked | |
|
Venture capital investments are provided to Texas-based startups.
|
Locked | Locked | Locked | |
|
Lumira Ventures is engaged in life sciences venture capital investment.
|
Locked | Locked | Locked |
Investor details for SpectraWAVE
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SpectraWAVE
Investment portfolio details for SpectraWAVE
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SpectraWAVE
Detailed financials for SpectraWAVE
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Spectrawave Comparisons
Peer comparison for SpectraWAVE
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SpectraWAVE
SpectraWAVE operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oxford Instruments, Leica Microsystems, IBA, GEN inCode and SD Biosensor, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Technology tools and systems for molecular scale are developed.
|
|
| Locked | Locked | Locked |
Imaging solutions for macro, micro, and nano structures are provided.
|
|
| Locked | Locked | Locked |
Innovative solutions for cancer treatment and industrial applications are provided by IBA.
|
|
| Locked | Locked | Locked |
Genetic and clinical data are integrated for precision cardiac medicines.
|
|
| Locked | Locked | Locked |
Biosensors for point-of-care diagnostics are developed by SD Biosensor.
|
Detailed competitors of SpectraWAVE
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Spectrawave
Complete news archive for SpectraWAVE
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SpectraWAVE
SpectraWAVE was founded in 2012 and raised its 1st funding round 7 years after it was founded.
SpectraWAVE is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Eman Namati is the current CEO of SpectraWAVE.
SpectraWAVE is a funded company, having raised a total of $79.88M across 3 funding rounds to date.
As of Dec 31, 2021, the latest employee count at SpectraWAVE is 36.
SpectraWAVE was founded in 2012 and is headquartered in Waltham, United States. Optical diagnostic and therapeutic devices are developed for the diagnosis and treatment of cardiovascular disease within the medical devices sector. Photonic imaging technology is employed to enable precise cardiovascular assessments. Operations center on advancing non-invasive solutions for clinical applications in cardiology.
SpectraWAVE's top competitors include Oxford Instruments, Leica Microsystems and IBA.
SpectraWAVE offers HyperVue Imaging System and Starlight Imaging Catheter.
SpectraWAVE has 9 investors. Key investors include Nova Ventures Group, Philips, Johnson & Johnson Innovation – JJDC, S3 Ventures, and Lumira Ventures.